New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024
17 Sep 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023
EORTC’s presence at ESMO 2023
17 Oct 2023
EORTC, CTI, and IRROG collaboration opens new opportunities in Ireland
12 Dec 2022
Results from monotherapy group in UPSTREAM demonstrate trial’s feasibility in head and neck squamous cell carcinoma
23 Nov 2021
First european biomarker driven umbrella trial in recurrent / metastatic squamous cell carcinoma of the head & neck
26 Jun 2017
Debiopharm and EORTC announce a collaboration to investigate Triptorelin for treatment of Salivary Gland Cancers
13 Jan 2016
